InvestSMART

Emyria Limited (ASX: EMD) - Announcements

- Current share price for EMD : $0.040

ASX company news and announcements for Emyria Limited (EMD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Emyria Limited (EMD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Emyria Limited (EMD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Emyria Limited (EMD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$32 Emyria wins digital health monitoring grant with UWA 5 Feb 2021 9:27AM $0.140 $0.040 fallen by 71.43%
$32 Letter to Shareholders - General Meeting 3 Feb 2021 7:13PM $0.125 $0.040 fallen by 68%
$32 Notice of General Meeting/Proxy Form 3 Feb 2021 7:12PM $0.125 $0.040 fallen by 68%
$32 Change in substantial holding SW 3 Feb 2021 7:09PM $0.125 $0.040 fallen by 68%
$32 Emyria adds consultant psychiatrist to Medical Advisory 1 Feb 2021 10:20AM $0.110 $0.040 fallen by 63.64%
$32 FDA Position on RWE to Guide Registration 27 Jan 2021 9:11AM $0.145 $0.040 fallen by 72.41%
$32 Appendix 4C - Quarterly 19 Jan 2021 9:59AM $0.135 $0.040 fallen by 70.37%
$32 Emyria Pursuing Registration of EMD-003 in CY2021 5 Jan 2021 9:17AM $0.100 $0.040 fallen by 60%
$32 Appendix 2A and Notice Under Section 708A 22 Dec 2020 5:25PM $0.087 $0.040 fallen by 54.02%
$32 Emyria to Benefit from Final TGA Ruling on CBD Medicines 16 Dec 2020 9:26AM $0.085 $0.040 fallen by 52.94%
$32 Proposed issue of Securities - EMD 16 Dec 2020 9:26AM $0.085 $0.040 fallen by 52.94%
$32 Proposed issue of Securities - EMD 16 Dec 2020 9:26AM $0.085 $0.040 fallen by 52.94%
$32 Proposed issue of Securities - EMD 16 Dec 2020 9:26AM $0.085 $0.040 fallen by 52.94%
$32 Emyria to Accelerate Drug Development with $1.2m Placement 16 Dec 2020 9:25AM $0.085 $0.040 fallen by 52.94%
$32 Trading Halt 14 Dec 2020 9:41AM $0.085 $0.040 fallen by 52.94%
$32 Product Launch Update 8 Dec 2020 9:56AM $0.086 $0.040 fallen by 53.49%
$32 Emyria Sees Strong Interest in IBS Study 3 Dec 2020 9:43AM $0.084 $0.040 fallen by 52.38%
$32 Emyria Launches Drug Development Program Based on RWE 25 Nov 2020 10:14AM $0.072 $0.040 fallen by 44.44%
$32 Emyria Partners with Thought Leaders in Psychedelic Therapy 19 Nov 2020 9:22AM $0.076 $0.040 fallen by 47.37%
$32 Change of Director's Interest Notice SW 16 Nov 2020 9:40AM $0.076 $0.040 fallen by 47.37%
$32 Change of Director's Interest Notice * 4 13 Nov 2020 7:44PM $0.076 $0.040 fallen by 47.37%
$32 Appendix 3G 13 Nov 2020 7:36PM $0.076 $0.040 fallen by 47.37%
$32 Results of Meeting 13 Nov 2020 3:08PM $0.076 $0.040 fallen by 47.37%
$32 Annual General Meeting Presentation 13 Nov 2020 9:40AM $0.079 $0.040 fallen by 49.37%
$32 Exercise Price of Options 13 Nov 2020 8:24AM $0.079 $0.040 fallen by 49.37%

476 - 500 of 573 results

Page 20 of 23

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.